Protective Effect of a New C5a Receptor Antagonist against Ischemia–Reperfusion Injury in the Rat Small Intestine

This publication has 42 references indexed in Scilit:

• Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonist
  British Journal of Pharmacology, 2001
• Regulators of the anaphylatoxin C5a
  Expert Opinion on Therapeutic Patents, 2000
• Role of Cytokines in the Pathogenesis of Inflammatory Bowel Disease
  Annual Review of Medicine, 2000
• Pharmacological characterization of antagonists of the C5a receptor
  British Journal of Pharmacology, 1999
• Effects of a new C5a receptor antagonist on C5a- and endotoxin- induced neutropenia in the rat
  British Journal of Pharmacology, 1999
• Antiinflammatory Effects of Soluble Complement Receptor Type 1 Promote Rapid Recovery of Ischemia/Reperfusion Injury in Rat Small Intestine
  Clinical Immunology, 1999
• The potential etiologic role of tumor necrosis factor in mediating multiple organ dysfunction in rats following intestinal ischemia-reperfusion injury
  Resuscitation, 1995
• Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide‐stimulated monocytes and macrophages
  European Journal of Immunology, 1990
• Increased levels of platelet-activating factor in blood following intestinal ischemia in the dog
  Biochemical and Biophysical Research Communications, 1989
• C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha.
  The Journal of Experimental Medicine, 1988